Gene · 837
Papers3,388
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
681 to 700 of 3,388
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mechanism of Emodin in the Treatment of Rheumatoid Arthritis. | Evid Based Complement Alternat Med | 2022 | 36225183 | PubTator, text mining | PubMed |
| The latest breakthrough on NLRP6 inflammasome. | Precis Clin Med | 2022 | 36211635 | PubTator, text mining | PubMed |
| Sepsis-induced immunosuppression: mechanisms, diagnosis and current treatment options. | Mil Med Res | 2022 | 36209190 | PubTator, text mining | PubMed |
| Bulk and Single-Cell Transcriptome Analyses Revealed That the Pyroptosis of Glioma-Associated Macrophages Participates in Tumor Progression and Immunosuppression. | Oxid Med Cell Longev | 2022 | 36199426 | PubTator, text mining | PubMed |
| System analysis based on the pyroptosis-related genes identifies GSDMC as a novel therapy target for pancreatic adenocarcinoma. | J Transl Med | 2022 | 36199146 | PubTator, text mining | PubMed |
| Identification of potential biomarkers and pathogenesis in neutrophil-predominant severe asthma: A comprehensive bioinformatics analysis. | Medicine (Baltimore) | 2022 | 36197221 | PubTator, text mining | PubMed |
| Lipopolysaccharide detection by the innate immune system may be an uncommon defence strategy used in nature. | Open Biol | 2022 | 36196535 | PubTator, text mining | PubMed |
| Values of a novel pyroptosis-related genetic signature in predicting outcome and immune status of pancreatic ductal adenocarcinoma. | Gastroenterol Rep (Oxf) | 2022 | 36196256 | PubTator, text mining | PubMed |
| Interleukin-22 regulates neutrophil recruitment in ulcerative colitis and is associated with resistance to ustekinumab therapy. | Nat Commun | 2022 | 36192482 | PubTator, text mining | PubMed |
| Human neutrophil IL1β directs intestinal epithelial cell extrusion during Salmonella infection. | PLoS Pathog | 2022 | 36191054 | PubTator, text mining | PubMed |
| A potential new pathway for heparin treatment of sepsis-induced lung injury: inhibition of pulmonary endothelial cell pyroptosis by blocking hMGB1-LPS-induced caspase-11 activation. | Front Cell Infect Microbiol | 2022 | 36189354 | PubTator, text mining | PubMed |
| Increased platelet activation and platelet-inflammasome engagement during chikungunya infection. | Front Immunol | 2022 | 36189282 | PubTator, text mining | PubMed |
| Pyroptosis in development, inflammation and disease. | Front Immunol | 2022 | 36189207 | PubTator, text mining | PubMed |
| Properties of flavonoids in the treatment of bladder cancer (Review). | Exp Ther Med | 2022 | 36185766 | PubTator, text mining | PubMed |
| Bibliometric analysis of global research trends on pyroptosis in lung disease. | Front Immunol | 2022 | 36177039 | PubTator, text mining | PubMed |
| A pyroptosis-associated signature plays a role in prognosis prediction in clear cell renal cell carcinoma. | BMC Med Genomics | 2022 | 36163033 | PubTator, text mining | PubMed |
| Osthole: An up-to-date review of its anticancer potential and mechanisms of action. | Front Pharmacol | 2022 | 36160431 | PubTator, text mining | PubMed |
| The subversion of toll-like receptor signaling by bacterial and viral proteases during the development of infectious diseases. | Mol Aspects Med | 2022 | 36152458 | PubTator, text mining | PubMed |
| Pyroptosis patterns of colon cancer could aid to estimate prognosis, microenvironment and immunotherapy: evidence from multi-omics analysis. | Aging (Albany NY) | 2022 | 36152052 | PubTator, text mining | PubMed |
| Pyroptosis and Its Role in the Modulation of Cancer Progression and Antitumor Immunity. | Int J Mol Sci | 2022 | 36142404 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/837/papers?page=35